January 22,Minimally Invasive Medical(00853) announced that it expects to turn a profit for the year ending December 31, 2025, with an estimated net profit of no less than US$20 million, compared to an audited net loss of approximately US$268 million for the year ending December 31, 2024.

The main reasons for the expected turnaround from loss to profit this time include continuous revenue growth, especially overseas business revenue increased by approximately 70% year-over-year; despite industry policy bringing downward pressure on product prices, gross margin improved by 2 to 3 percentage points year-over-year through cost optimization measures; operating expenses decreased by approximately 10~11% year-over-year; and the disposal of a subsidiary contributed positive gains to the group.